Kevin Feeley - 01 Mar 2026 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Bridget Brown, Attorney-in-Fact
Issuer symbol: WGS
Transactions as of: 01 Mar 2026
Net transactions value: -$22,248
Form type: 4
Filing time: 03 Mar 2026, 16:38:41 UTC
Previous filing: 02 Feb 2026
Next filing: 05 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Feeley Kevin	CHIEF FINANCIAL OFFICER	C/O GENEDX HOLDINGS CORP., 333 LUDLOW ST., NORTH TOWER, 6TH FLOOR, STAMFORD	/s/ Bridget Brown, Attorney-in-Fact	03 Mar 2026	0001944119

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WGS	Class A Common Stock	Options Exercise	$0	+718	+7.8%	$0.000000	9,886	01 Mar 2026	Direct	F1
transaction	WGS	Class A Common Stock	Sale	$22,248	-287	-2.9%	$77.52	9,599	02 Mar 2026	Direct	F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WGS	Restricted Stock Unit	Options Exercise	$0	-718	-33%	$0.000000	1,434	01 Mar 2026	Class A Common Stock	718		Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.99 to $77.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 9,599 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 112,032 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
F5	6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.